https://www.zonebourse.com/cours/action/NYMOX-PHARMACEUTICAL-CORP-25054783/actualite/L-auditeur-de-Nymox-Pharmaceutical-Corporation-souleve-un-doute-sur-la-perennite-de-l-entreprise-41746186/?utm_source=telegram&utm_medium=social&utm_campaign=share